Skip to main content
OpenTrials

Clinical trial condition

Bone Diseases, Metabolic

Explore clinical trials studying Bone Diseases, Metabolic. Study availability and eligibility vary by location and protocol.

1,300 public trials 115 recruiting studies
Refine in advanced search Browse all conditions

Bone Diseases, Metabolic trial results

Completed

A Study of Monthly Risedronate for Osteoporosis

NCT00247273

Conditions
Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +5 more
Locations
  • Research Site Lakewood, Colorado, United States
  • Research Site Gainesville, Georgia, United States
  • Research Site Bethesda, Maryland, United States
  • Research Site Omaha, Nebraska, United States
View all 49 locations
View Trial Details
Completed

A Study of a 35 mg Delayed Release Formulation of Risedronate for Osteoporosis

NCT00541658

Conditions
Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +5 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Oakland, California, United States
  • Research Site San Diego, California, United States
  • Research Facility Walnut Creek, California, United States
View all 45 locations
View Trial Details
Completed

Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women

NCT00205777

Conditions
Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +3 more
Locations
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Huntsville, Alabama, United States
View all 375 locations
View Trial Details
Completed

Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic Women

NCT00927186

Conditions
Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +5 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lakewood, Colorado, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Atlanta, Georgia, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gainesville, Georgia, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bethesda, Maryland, United States
View Trial Details
Completed

CR9112792, a Follow-up of Study CR9108963

NCT00891553

Conditions
Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +4 more
Locations
  • GSK Investigational Site Ballerup Municipality, Denmark
  • GSK Investigational Site Bergen, Norway
  • GSK Investigational Site Hamar, Norway
View Trial Details

Related conditions